The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic ...

We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...

The rival bid from the 23andMe co-founder and former CEO at one point drew interest from a Fortune 500 company with more than ...

Nice 23andMe sale hearing ya got there — shame if something happened to it, say attorneys for co-founder and former CEO who ...

Me, which helped popularize ancestry tracing through genetic testing, filed for bankruptcy protection and will seek a sale.

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

How exactly 23andMe will shake out after the Regeneron purchase is to be seen. The company has taken a dramatic fall in ...

The acquisition comes two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Biotechnology leader Regeneron Pharmaceuticals is acquiring genetic testing firm 23andMe for $256 million following its ...

Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal ...